Nicotine replacement therapy and cardiovascular disease

Mayo Clinic Proceedings

Volumn 80, Issue 5, 2005, Pages 652-656

  Ford, Catherine L ^a   Zlabek, Jonathan A ^a  

^a GUNDERSEN LUTHERAN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; NICOTINE; NICOTINE GUM;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; DRUG EFFICACY; DRUG SAFETY; HEALTH CARE PERSONNEL; HUMAN; LOZENGE; NICOTINE REPLACEMENT THERAPY; POPULATION; REVIEW; SMOKING CESSATION; TOBACCO;

EID: 18244374434     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/80.5.652     Document Type: Review

References (42)

1. Centers for Disease Control and Prevention. 1964 Surgeon General report: reducing the health consequences of smoking. Chapter 4: summaries and conclusions. Available at: www.cdc.gov/tobacco/sgr/sgr_1964/sgr64.htm. Accessibility verified February 15, 2005.
2. US Public Health Service, Office of the Surgeon General. Reducing the Health Consequences of Smoking: 25 Years of Progress: A Report of the Surgeon General. Washington, DC: Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 1989. DHHS publication CDC 89-8411.
3. Centers for Disease Control and Prevention. Cigarette smoking among adults - United States, 2002. MMWR Morb Mortal Wkly Rep. 2004;53:427-431.
4. Centers for Disease Control and Prevention. Health effects of cigarette smoking: fact sheet. Available at: www.cdc.gov/tobacco/factsheets /HealthEffectsofCigaretteSmoking_Factsheet.htm. Accessibility verified February 15, 2005.
5. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction - executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). J Am Coll Cardiol. 2004;44:671-719.
6. Critchley JA, Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA. 2003;290:86-97.
7. Wilson K, Gibson N, Willan A, Cook D. Effect of smoking cessation on mortality after myocardial infarction: meta-analysis of cohort studies. Arch Intern Med. 2000;160:939-944.
8. Glover ED, Glover PN, Payne TJ. Treating nicotine dependence. Am J Med Sci. 2003;326:183-186.
9. Fiore MC, Smith SS, Jorenby DE, Baker TB. The effectiveness of the nicotine patch for smoking cessation: a meta-analysis. JAMA. 1994;271:1940-1947.
10. US Department of Health and Human Services, Public Health Services, Fiore MC, Bailey WC, Cohen SJ, et al. Treating Tobacco Use and Dependence: Clinical Practice Guideline. Rockville, Md: US Dept of Health and Human Services, Public Health Service; June 2000:25-90.
11. Benowitz NL, Gourlay SG. Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy. J Am Coll Cardiol. 1997;29:1422-1431.
12. Smith CJ, Fischer TH. Particulate and vapor phase constituents of cigarette mainstream smoke and risk of myocardial infarction. Atherosclerosis. 2001;158:257-267.
13. Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol. 2004;43:1731-1737.
14. Fröhlich M, Sund M, Löwel H, Imhof A, Hoffmeister A, Koenig W. Independent association of various smoking characteristics with markers of systemic inflammation in men: results from a representative sample of the general population (MONICA Augsburg Survey 1994/95). Eur Heart J. 2003; 24:1365-1372.
15. Nair S, Kulkarni S, Camoens HM, Ghosh K, Mohanty D. Changes in platelet glycoprotein receptors after smoking - a flow cytometric study. Platelets. 2001;12:20-26.
16. Mundal HH, Hjemdahl P, Gjesdal K. Acute effects of low dose nicotine gum on platelet function in non-smoking hypertensive and normotensive men. Eur J Clin Pharmacol. 1995;47:411-416.
17. Blann AD, Steele C, McCollum CN. The influence of smoking and of oral and transdermal nicotine on blood pressure, and haematology and coagulation indices. Thromb Haemost. 1997;78:1093-1096.
18. Benowitz NL, Fitzgerald GA, Wilson M, Zhang Q. Nicotine effects of eicosanoid formation and hemostatic function: comparison of transdermal nicotine and cigarette smoking. J Am Coll Cardiol. 1993;22:1159-1167.
19. Lucini D, Bertocchi F, Malliani A, Pagani M. Autonomic effects of nicotine patch administration in habitual cigarette smokers: a double-blind, placebo-controlled study using spectral analysis of RR interval and systolic arterial pressure variabilities. J Cardiovasc Pharmacol. 1998;31:714-720.
20. Zevin S, Jacob P III, Benowitz NL. Dose-related cardiovascular and endocrine effects of transdermal nicotine. Clin Pharmacol Ther. 1998;64:87-95.
21. Tzivoni D, Keren A, Meyler S, Khoury Z, Lerer T, Brunel P. Cardiovascular safety of transdermal nicotine patches in patients with coronary artery disease who try to quit smoking. Cardiovasc Drugs Ther. 1998;12:239-244.
22. Mall T, Grossenbacher M, Perruchoud AP, Ritz R. Influence of moderately elevated levels of carboxyhemoglobin on the course of acute ischemic heart disease. Respiration. 1985;48:237-244.
23. Keeley EC, Pirwitz MJ, Landau C, et al. Intranasal nicotine spray does not augment the adverse effects of cigarette smoking on myocardial oxygen demand or coronary arterial dimensions. Am J Med. 1996;101:357-363.
24. Nitenberg A, Antony I. Effects of nicotine gum on coronary vasomotor responses during sympathetic stimulation in patients with coronary artery stenosis. J Cardiovasc Pharmacol. 1999;34:694-699.
25. Palmer KJ, Buckley MM, Faulds D. Transdermal nicotine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy as an aid to smoking cessation. Drugs. 1992;44:498-529.
26. Mahmarian JJ, Moye LA, Nasser GA, et al. Nicotine patch therapy in smoking cessation reduces the extent of exercise-induced myocardial ischemia. J Am Coll Cardiol. 1997;30:125-130.
27. Bermudez EA, Rifai N, Buring JE, Manson JE, Ridker PM. Relation between markers of systemic vascular inflammation and smoking in women. Am J Cardiol. 2002;89:1117-1119.
28. Nedeljkovic ZS, Gokce N, Loscalzo J. Mechanisms of oxidative stress and vascular dysfunction. Postgrad Med J. 2003;79:195-199.
29. Hwang SL, Waldholz M. Heart attacks reported in patch users still smoking. Wall Street Journal. June 19, 1992;sect B I.
30. Ottervanger JP, Festen JM, de Vries AG, Stricker BH. Acute myocardial infarction while using the nicotine patch. Chest. 1995;107:1765-1766.
31. Ropchan GV, Sanfilippo AJ, Ford SE. Aortic dissection and use of the nicotine patch: a case involving a temporal relationship. Can J Cardiol. 1997; 13:525-528.
32. Van der Klauw MM, Van Hillo B, Van deu Berg WH, Bolsius EP, Sutorius FF, Stricker BH. Vasculitis attributed to the nicotine patch (Nicotinell). Br J Dermatol. 1996;134:361-364.
33. Dacosta A, Guy JM, Tardy B, et al. Myocardial infarction and nicotine patch: a contributing or causative factor? Eur Heart J. 1993;14:1709-1711.
34. Pierce JR Jr. Stroke following application of a nicotine patch [letter]. Ann Pharmacother. 1994;28:402.
35. Warner JG Jr, Little WC. Myocardial infarction in a patient who smoked while wearing a nicotine patch [letter]. Ann Intern Med. 1994;120:695.
36. Riche G, Nighoghossian N, Trouillas P. Intracerebral haematoma after application of nicotine patch [letter]. Lancet. 1995;346:777-778.
37. Mathew TP, Herity NA. Acute myocardial infarction soon after nicotine replacement therapy [letter]. QJM. 2001;94:503-504.
38. Working Group for the Study of Transdermal Nicotine in Patients With Coronary Artery Disease. Nicotine replacement therapy for patients with coronary artery disease. Arch Intern Med. 1994;154:989-995.
39. Joseph AM, Norman SM, Ferry LH, et al. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. N Engl J Med. 1996;335:1792-1798.
40. Greenland S, Satterfield MH, Lanes SF. A meta-analysis to assess the incidence of adverse effects associated with the transdermal nicotine patch. Drug Saf. 1998;18:297-308.
41. Kimmel SE, Berlin JA, Miles C, Jaskowiak J, Carson JL, Strom BL. Risk of acute first myocardial infarction and use of nicotine patches in a general population. J Am Coll Cardiol. 2001;37:1297-1302.
42. US Public Health Service. Clinician's packet: treating tobacco use and dependence: a how-to guide for implementing the Public Health Service clinical practice guideline. March 2003. Available at: www.surgeongeneral .gov/tobacco/clinpack.html. Accessibility verified February 15, 2005.